drugset / Trial / NCT00228514

Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub Study

NCT00228514

Phase 3 Completed 40 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

At one site, patients participating in the Corona main study are asked to participate in the PET-substudy. Before and 6 months after study medication is started a Positron Emission Tomography (PET-scan) is performed to study the effect of rosuvastatin in Chronic Heart Failure on myocardial perfusion (reserve)

Timeline

Start
2004-02
Primary completion
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule